Literature DB >> 18068563

Secondary chronic venous disorders.

Mark H Meissner1, Bo Eklof, Phillip Coleridge Smith, Michael C Dalsing, Ralph G DePalma, Peter Gloviczki, Gregory Moneta, Peter Neglén, Thomas O' Donnell, Hugo Partsch, Seshadri Raju.   

Abstract

Secondary chronic venous disorders (CVD) usually follow an episode of acute deep venous thrombosis (DVT). Most occluded venous segments recanalize over the first 6 to 12 months after an episode of acute DVT, leading to chronic luminal changes and a combination of partial obstruction and reflux. Such morphological changes produce venous hypertension with the highest levels of ambulatory venous pressure occurring in patients with combined outflow obstruction and distal reflux. The clinical manifestations of secondary CVD, including pain, venous claudication, edema, skin changes, and ulceration are commonly referred to as the post-thrombotic syndrome. Such sequelae are best avoided by early and aggressive treatment of proximal DVT. The diagnostic evaluation of secondary CVD is similar to primary CVD and is based upon duplex ultrasound. However, the definition of hemodynamically significant venous stenosis remains obscure and there are no reliable tests to confirm the presence of such lesions. Diagnosis depends more on anatomic rather than hemodynamic criteria, and IVUS is superior to venography in estimating the morphological degree and extent of iliac vein stenosis. The fundamental role of compression in the treatment of CVD is well recognized. Compliance with compression is essential to heal ulcers and minimize recurrence. The efficacy of various adjuncts to ulcer treatment, including complex wound dressings and medications have been variable. Although superficial venous surgery has not been demonstrated to improve ulcer healing rates, it does decrease ulcer recurrence. Deep venous valve reconstruction is performed in only a few specialized centers, and the results are better for primary than for secondary CVD. Treatment of incompetent perforating veins remains controversial. Although artificial venous valves are promising, most early experimental models have failed. With respect to venous obstruction, iliocaval angioplasty and stenting has emerged as the primary treatment for proximal iliofemoral venous obstruction with surgical bypass assuming a secondary role.

Entities:  

Mesh:

Year:  2007        PMID: 18068563     DOI: 10.1016/j.jvs.2007.08.048

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  21 in total

1.  Iliocaval vein stenting: Long term survey of postthrombotic symptoms and working capacity.

Authors:  Alaa Alhadad; Tilo Kölbel; Andreas Herbst; Jan Holst; Hussein Alhadad; Anders Gottsäter
Journal:  J Thromb Thrombolysis       Date:  2011-02       Impact factor: 2.300

2.  Quality of life and the venous function of the lower limb after harvest of autologous external iliac vein grafts: a clinical follow-up study.

Authors:  Yuji Kaneoka; Atsuyuki Maeda; Masayuki Sugimoto; Masatoshi Isogai; Hiroyuki Ishibashi
Journal:  Surg Today       Date:  2012-11-10       Impact factor: 2.549

Review 3.  Evaluation and Management of Chronic Venous Disease Using the Foundation of CEAP.

Authors:  Teresa L Carman; Ali Al-Omari
Journal:  Curr Cardiol Rep       Date:  2019-08-30       Impact factor: 2.931

4.  Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research.

Authors:  Ferdinando Mannello; Joseph D Raffetto
Journal:  Am J Transl Res       Date:  2010-11-23       Impact factor: 4.060

5.  High day-to-day reliability in lower leg volume measured by water displacement.

Authors:  Jeffrey D Pasley; Patrick J O'Connor
Journal:  Eur J Appl Physiol       Date:  2008-07       Impact factor: 3.078

6.  Clinician's perspectives on the treatment of venous leg ulceration.

Authors:  George H Cullen; Tania J Phillips
Journal:  Int Wound J       Date:  2009-10       Impact factor: 3.315

7.  Endovascular stent treatment for symptomatic benign iliofemoral venous occlusive disease: long-term results 1987-2009.

Authors:  A Gutzeit; Ch L Zollikofer; M Dettling-Pizzolato; N Graf; J Largiadèr; C A Binkert
Journal:  Cardiovasc Intervent Radiol       Date:  2010-07-01       Impact factor: 2.740

8.  The design, development, and evaluation of a prototypic, prosthetic venous valve.

Authors:  Matt T Oberdier; Stanley E Rittgers
Journal:  Biomed Eng Online       Date:  2008-09-19       Impact factor: 2.819

9.  RASA1-driven cellular export of collagen IV is required for the development of lymphovenous and venous valves in mice.

Authors:  Di Chen; Xin Geng; Philip E Lapinski; Michael J Davis; R Sathish Srinivasan; Philip D King
Journal:  Development       Date:  2020-12-07       Impact factor: 6.862

10.  Excellent long-term results with iliac stenting in local anesthesia for post-thrombotic syndrome.

Authors:  Lotte Klitfod; Sven Just; Pia Foegh; Niels Baekgaard
Journal:  Acta Radiol Open       Date:  2015-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.